期刊
BREAST CANCER RESEARCH
卷 10, 期 6, 页码 -出版社
BIOMED CENTRAL LTD
DOI: 10.1186/bcr2207
关键词
-
类别
资金
- NIH [CA95004, CA114301, CA1179151]
- US Department of Defense [W81XWH-08-1-0249]
- NATIONAL CANCER INSTITUTE [R01CA095004, R01CA114301] Funding Source: NIH RePORTER
Eph receptor tyrosine kinase signaling regulates cancer initiation and metastatic progression through multiple mechanisms. Studies of tumor-cell-autonomous effects of Eph receptors demonstrate their dual roles in tumor suppression and tumor promotion. In addition, Eph molecules function in the tumor microenvironment, such as in vascular endothelial cells, influencing the ability of these molecules to promote carcinoma progression and metastasis. The complex nature of Eph receptor signaling and crosstalk with other receptor tyrosine kinases presents a unique challenge and an opportunity to develop therapeutic intervention strategies for targeting breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据